Clinical trial
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia…
NCT00112619 · Pediatric Brain Tumor Consortium, Other · Terminated
Key facts
| NCT number | NCT00112619 |
|---|---|
| Title | Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors |
| Official title | A Phase I Pharmacokinetic Optimal Dosing Study of Intraventricular Topotecan for Children With Neoplastic Meningitis |
| Lead sponsor | Pediatric Brain Tumor Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Leukemia, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride |
| Enrollment | 19 |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2010 |
| First posted | Jun 3, 2005 |
| Last update posted | Jun 30, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: